dna13
Latest round
- Series B
Last raised
- Oct 2008
Total raised
- $7.8M
Investors
- 2
About dna13
dna13 Inc.Founded in 2001 in New York, US, dna13 Inc. operates within the domain name market. In April 2010, the company was acquired by CNW Group Ltd.The company's primary offering is the sale of premium domain names, with a focus on the online real estate market.58 over a 12-month period. This service targets various end-users, including entrepreneurs, small business owners, and individuals looking to establish a personal brand online. The company caters to a global market, enabling clients from diverse geographical regions to acquire domain names that are vital for their online presence.The company generates revenue through the direct sale of domain names and associated services. Transactions occur primarily on a B2C basis, where individuals or businesses purchase domain names directly from the company. The pricing structure is straightforward; clients pay a one-time fee or opt for a monthly payment plan to acquire their desired domain.com.As of now, dna13 Inc. has not publicly outlined specific new products in development or targeted upcoming markets for expansion.80 mn will likely support operational growth and could enhance their domain offerings and service capabilities.
Who invested in dna13
2 investors across 2 rounds
See all investors in dna13
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about dna13
Who invested in dna13?
dna13 has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has dna13 raised?
dna13 has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did dna13 last raise money?
dna13's most recent round on record is a Series B, in Oct 2008.
What does dna13 do?
dna13 is a software company.
Where is dna13 headquartered?
dna13 is headquartered in New York, US.
Which VCs invest in companies like dna13?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at dna13's stage. Their profiles are linked below.
VCs backing software startups at Series B
Raising like dna13? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.